Related Experiment Video
Updated: Jun 18, 2026

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
RNF213 isoform 2 restricts Zika virus through antiviral signaling and viral protein degradation
Xiaoyu Yang1, Teng Chen2,3, Bin Ren4
1Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Abstract:
Several RING finger (RNF) family proteins exert antiviral effects primarily by regulating host antiviral pathways. Moreover, the longer isoform of RNF213 can also directly target viral proteins to inhibit infection. However, the antiviral potential of the shorter isoform of RNF213 (RNF213 isoform 2) remains unexplored. Here, we report that RNF213 isoform 2 (hereafter referred to as RNF213) activates the retinoic acid-inducible gene I (RIG-I)-melanoma differentiation-associated gene 5 (MDA5) pathway and promotes proteasomal and lysosomal degradation of multiple Zika virus (ZIKV) proteins, including the capsid (C), envelope (E), nonstructural 3 (NS3), and nonstructural 4B (NS4B) proteins, to restrict ZIKV infection. Notably, we identified a 23-amino acid peptide (PR-23) derived from RNF213 that degrades ZIKV proteins and suppresses viral replication in vitro. In conclusion, our findings not only elucidate a dual-targeting antiviral mechanism of RNF213 against ZIKV but also define a minimal functional domain of this isoform that mediates antiviral activity in vitro.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Virion Maturation and Assembly

